Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.

Clin Pharmacokinet · 2016 · PMC4875959 · PMID 26597252

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a similar study, after 4 weeks of treatment, there was a trend towards lower energy intake and higher energy expenditure with liraglutide compared with placebo or glimepiride, although these effects did not reach statistical significance [ 62 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.